PEDIATRICS Vol. 20 No. 2 August 1957, pp. 257-267
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Markowitz, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Markowitz, M.

OBSERVATIONS ON AN EPIDEMIC OF STREPTOCOCCAL INFECTIONS AND RECURRENCES OF RHEUMATIC FEVER AMONG CHILDREN TREATED WITH PENICILLIN

Milton Markowitz M.D.1

1 The Happy Hills Convalescent Hospital, the Department of Pediatrics, Johns Hopkins Hospital and School of Medicine, and the Department of Pediatrics, Sinai Hospital, Baltimore, Maryland

An outbreak of streptococcal pharyngitis among children in a convalescent hospital has been described. Eleven of thirty-three subjects with rheumatic fever, under close observation, developed group A streptococcal infections while they received a single daily oral dose of 200,000 units of benzathine penicillin G.

Treatment of the streptococcal infections was carried out with therapeutic doses of various penicillin preparations. Four children who received single injections of 600,000 units of benzathine penicillin G, developed recurrences of rheumatic fever.

The results of the study indicate that a single daily oral dose of 200,000 units of benzathine penicillin G is inadequate for the prevention of streptococcal infections in a closed or semiclosed community of rheumatic fever subjects. It is suggested that at least twice this dosage be employed in such an environment. The data based on a small series of cases suggest that the treatment of acute streptococcal infections with a single intramuscular dose of 600,000 units of benzathine penicillin G will not prevent recurrences of rheumatic fever in highly susceptible patients.

Submitted on October 18, 1956
Accepted on January 16, 1957